Trial intelligence / Profile preview

Step-down therapy trial in mild to moderate asthma

ChiCTR1800020279Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Dec 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of budesonide and formoterol in asthma (5 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Asthma control test, Asthma control questionnaire and 3 more. Started Dec 2018; status: recruiting.

02

Drugs

budesonideformoterol
03

Conditions

asthma

Beyond the preview

Go deeper on ChiCTR1800020279.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800020279.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call